Global Dilated Cardiomyopathy Therapeutics Industry
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Global Dilated Cardiomyopathy Therapeutics Industry - https://www.reportlinker.com/p05960610/?utm source=GNW
6 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Aldosterone Antagonists, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$40.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Angiotensin-Converting Enzyme (ACE) Inhibitors segment is readjusted to a revised 3.4% CAGR for the next 7-year period.